🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
OK Biotech Co., Ltd. (TPE:4155)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
15.50
-0.70 (-4.32%)
Nov 20, 2026, 1:30 PM CST

OK Biotech Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,7231,5561,6701,1921,4841,263
Revenue Growth
5.09%-6.81%40.11%-19.65%17.42%-14.89%
Cost of Revenue
1,1761,1271,394995.11,1391,077
Gross Profit
546.74429.25275.66196.88344.96186.83
Selling, General & Admin
249.15251.07177.25148.41156.09148.24
Research & Development
67.9559.0457.9346.7148.7328.74
Other Operating Expenses
-74.68--6.29-7.437.06-4.93
Operating Expenses
253.66321.36218.44208.95243.15178.74
Operating Income
293.08107.8957.21-12.06101.818.09
Interest Expense
-8.86-10.92-6.23-9-11.42-8.08
Interest & Investment Income
4.33.426.17.154.431.3
Earnings From Equity Investments
2.720.585.115.337.4324.65
Currency Exchange Gain (Loss)
-18.83-18.8349.28-9.8659.91-9.19
Other Non Operating Income (Expenses)
52.9318.7613.3323.6918.0428.26
EBT Excluding Unusual Items
325.33100.9124.85.24180.245.03
Impairment of Goodwill
-----6-
Gain (Loss) on Sale of Investments
-----0.19
Gain (Loss) on Sale of Assets
2.962.962.312.781.40.92
Pretax Income
328.3103.87127.118.03175.5946.14
Income Tax Expense
57.816.7420.799.6238.8714.72
Earnings From Continuing Operations
270.4997.13106.32-1.59136.7331.42
Minority Interest in Earnings
-19.47-14.68-12.344.546.7412.04
Net Income
251.0382.4593.982.95143.4643.46
Net Income to Common
251.0382.4593.982.95143.4643.46
Net Income Growth
265.14%-12.26%3087.75%-97.95%230.09%-66.50%
Shares Outstanding (Basic)
1211271281159493
Shares Outstanding (Diluted)
127131131115117106
Shares Change
-1.34%-0.35%14.02%-1.41%9.95%18.84%
EPS (Basic)
2.070.650.730.031.530.47
EPS (Diluted)
1.970.640.720.021.300.46
EPS Growth
274.82%-11.55%3121.00%-98.28%182.57%-68.83%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
263.56-90.28-310.79-426.74-46.31-57.16
Free Cash Flow Per Share
2.07-0.69-2.37-3.71-0.40-0.54
Dividend Per Share
0.3350.3350.3350.3351.2441.012
Dividend Growth
0%0%0%-73.11%22.94%-28.57%
Gross Margin
31.73%27.58%16.51%16.52%23.25%14.79%
Operating Margin
17.01%6.93%3.43%-1.01%6.86%0.64%
Profit Margin
14.57%5.30%5.63%0.25%9.67%3.44%
Free Cash Flow Margin
15.30%-5.80%-18.61%-35.80%-3.12%-4.52%
EBITDA
369.15187.37125.2560.32165.9459.73
EBITDA Margin
21.43%12.04%7.50%5.06%11.19%4.73%
D&A For EBITDA
76.0879.4868.0472.3864.1351.64
EBIT
293.08107.8957.21-12.06101.818.09
EBIT Margin
17.01%6.93%3.43%-1.01%6.86%0.64%
Effective Tax Rate
17.61%6.49%16.36%119.86%22.13%31.90%